IGF-1 LR3 1mg

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg³) is a modified analogue of naturally occurring IGF-1, engineered to extend biological stability and reduce binding to IGF-binding proteins. This structural modification allows for prolonged receptor interaction and enhanced bioavailability in research settings.
 
IGF-1 LR3 has been studied for its role in cell growth signaling, protein synthesis pathways, and cellular regeneration mechanisms, particularly in contexts involving muscle cell biology, metabolic signaling, and tissue repair research. Due to its extended activity profile, it is often explored where sustained IGF-1 pathway engagement is required.
 
This product is supplied in a 1mg lyophilized vial and is intended for research and professional use only, under appropriate clinical oversight.
 
Key Characteristics:
 
Modified IGF-1 analogue with extended activity profile
Studied for cellular growth and regenerative signaling pathways
Reduced binding to IGF-binding proteins in research settings
Explored in muscle, metabolic, and tissue repair biology
Supplied in lyophilized form
 
Important Notice:
This product is not intended to diagnose, treat, cure, or prevent any disease. Intended for use by qualified professionals in accordance with applicable regulations.